C1101610||MiR-21-5p
C0017362||Functional Regulator
C1334533||Mesothelin
C0017262||Expression
C1101610||MicroRNA
C2936622||Next Generation Sequencing
C1101610||MicroRNAs
C1101610||MicroRNAs
C0887909||small non-coding RNAs
C0017263||regulate
C1515670||mRNA expression
C0598496||silencing
C1519595||transcripts
C1167622||binding
C0314659||miRNA recognition elements (MREs)
C0600600||3'untranslated region
C0600600||3'untranslated region
C2323869||bona fide
C0243095||researchers working
C1101610||MicroRNAs
C1159274||biotinylated
C0012854||DNA
C0079925||antisense oligonucleotides
C0035696||mRNA
C1523523||miRNAs::mRNA interactions
C1325880||physiological cellular
C1334533||mesothelin (MSLN) gene
C2936622||next generation sequencing
C2936622||next generation sequencing
C1101610||MicroRNAs
C0017263||regulate
C1334533||MSLN mRNA
C0428479||protein levels
C0812413||malignant pleural mesothelioma
C0812413||malignant pleural mesothelioma
C1159274||Biotinylated
C1334533||MSLN oligos
C1099355||miRNA::MSLN mRNA complexes
C0007600||cell line (Met-5A)
C1171362||expresses
C0380162||mesothelin
C1101610||MiRNAs
C1334533||MSLN mRNA
C2936622||next generation sequencing
C1101610||miR-21-5p
C1101610||miR-100-5p
C0936012||validation analyses
C1101610||MiR-21-5p
C0443264||modulate
C1334533||mesothelin
C0017262||expression
C1101610||miRNA
C0393040||mimic
C0681814||experiments
C0334227||malignant
C0007600||cell lines
C1101610||miRNA
C0681814||experiments
C0024075||luciferase
C0005507||assays
C0007634||Mero-14 cells
C1101610||miR-21-5p
C0017362||regulator
C1334533||mesothelin
C0087111||treatment
C1101610||miR-21-5p
C0393040||mimic
C0812413||malignant pleural mesothelioma
C0007600||cell lines
C2936622||next generation sequencing
C1519941||validation
C1523523||miRNA::mRNA interactions
C1101610||MiR-21-5p
C0017362||regulator
C1334533||mesothelin
C0007595||cellular growth